David Smelson to Risperidone
This is a "connection" page, showing publications David Smelson has written about Risperidone.
Connection Strength
0.901
-
Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. J Subst Abuse Treat. 2004 Jul; 27(1):45-9.
Score: 0.222
-
Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry. 2002 Sep; 47(7):671-5.
Score: 0.196
-
Roy A, Roy M, Smelson DA. Risperidone, ERG and cocaine craving. Am J Addict. 1998; 7(1):90.
Score: 0.142
-
Smelson DA, Roy A, Roy M. Risperidone diminishes cue-elicited craving in withdrawn cocaine-dependent patients. Can J Psychiatry. 1997 Nov; 42(9):984.
Score: 0.140
-
Smelson DA, Roy A, Roy M. Risperidone and neuropsychological test performance in cocaine-withdrawn patients. Can J Psychiatry. 1997 May; 42(4):431.
Score: 0.135
-
Smelson DA, Tunis SL, Nyhuis AW, Faries DE, Kinon BJ, Ascher-Svanum H. Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use. J Clin Psychopharmacol. 2006 Dec; 26(6):666-7.
Score: 0.066